These findings fill a critical gap in understanding how KDM5C‐driven epigenetic regulation impacts lncRNA expression in CRC, and they offer a novel theoretical foundation for considering KDM5C as a potential therapeutic target in CRC. The gene discussed is KDM5C; the disease is colorectal carcinoma.